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Abstact 
 
Sialic acid, oral glucose and plasma lipids were determined in 70 control  subjects age range 
20-60 and 150 individuals of age range 20-60 who were offspring of one type 2 diabetic par-
ent. The number of first degree relatives who had impaired glucose tolerance were 50. The 
total sialic acid concentration was significantly higher (p<0.05) in the first degree relatives 
when compared to the control subjects. However the total sialic acid concentration was sig-
nificantly higher in the offspring with normal glucose tolerance than those with impaired 
glucose tolerance. There was no significant difference in the lipids between the control sub-
jects and the offspring with normal glucose tolerance. But the total cholesterol and triglyc-
erides were significantly higher in the offspring with impaired glucose tolerance when com-
pared to the control subjects and the offspring with normal glucose tolerance. Our study 
shows that the desialylation of the vascular endothelium is an early event that precedes the 
expression of impaired glucose tolerance or any lipid changes in asymptomatic offspring of 
one type 2 diabetic parent. 
 
Introduction 
 
Identification of diabetic patients at risk for accelerated 
development of vascular disease is a major challenge. In 
the majority of the populations, both genetic and envi-
ronmental influences interact to determine individual risk 
of type 2 diabetes mellitus [1]. Subjects with type 2 diabe-
tes mellitus are at increased risk for the development of 
both macrovascular and microvascular complications [2]. 
At the time of diagnosis,  the existence of  atherosclerotic 
manifestations is already widespread in the  patients with 
type 2 diabetes mellitus but the prevalence of coronary 
artery disease (CAD ) has no correlation with the duration 
of diabetes [2,3] 
 
It is widely accepted that frank clinical type 2 diabetes is 
preceded by a long prediabetic stage [4]. Impaired gluco- 
 
 
se tolerance (IGT) is a widely accepted entity of the pre-
diabetic stage  and is associated with hypertension, obe-
sity, insulin resistance and dyslipoproteinemia commonly 
known as metabolic syndrome X  [5]. It is even possible 
that type 2 diabetes and CAD may share common antece-
dents [6,7] and the so called insulin resistance syndrome 
could be such a common factor. More complex abnor-
malities include changes in the composition of lipopro-
teins leading to increased production of atherogenic 
“remnant particles” [8], increased non enzymatic glycosy-
lation and desialylation [9]. Studies have shown that non 
diabetic individuals with a positive family history of dia-
betes have elevated cardiovascular risk factors relative to 
nondiabetic individuals without such family history [10]. 
Therefore it is possible that the prediabetic phase could be 
a period of enhanced cardiovascular risk. Impaired glu-
cose tolerance is commonly believed to represent the tran-
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sitional stage between normal and diabetic glucose toler-
ance. Although it has been proven to be a risk factor for 
cardiovascular disease, it is not a reliable marker [11]. 
Therefore it is of paramount importance to determine 
some definitive early markers to identify the people at 
high risk. 
 
The steps by which type 2 diabetes causes atherosclerotic 
vascular disease is not clear. Emphasis is shifting from 
elucidation of risk factors such as insulin resistance to an 
understanding of the process occurring at the vasculature 
[12,13]. Increase in the concentration of serum sialic acid 
has been shown to be a possible cardiovascular risk factor 
in patients with non insulin dependent diabetes [14]. The 
earliest event associated with atherosclerosis is the accu-
mulation of low density lipoprotein (LDL) cholesterol and 
fibrinogen/fibrin in the affected arterial wall [15]. It is 
therefore important to understand the mechanisms, which 
govern the endothelial binding, uptake and transport of 
these macromolecules across the vessel wall as a prereq-
uisite to the prevention of atherogenesis. The role of the 
luminal endothelial plasma membrane may be particularly 
relevant because it is the first interface between the vessel 
wall and circulating blood components. The luminal sur-
face of the endothelium is rich in sialoglycated proteins 
and thus provides an anionic barrier for the receptor me-
diated uptake of LDL. It has been shown that the removal 
of the sialic acid as well as the glycosaminoglycans, in-
creases the internalization of LDL by 20 fold [16].  There-
fore, desialylation of the endothelium could be an early 
event in the atherosclerotic process in cardiovascular dis-
ease and in type 2 diabetes mellitus. The accumulated 
LDL particles in the arterial walls are oxidized which in 
turn stimulates the production of adhesion molecules [17]. 
The adhesion molecules play a role in the early stages of 
vascular disease by facilitating the attachment and the 
transmigration of the leucocytes through the endothelium 
[18] which leads to the accumulation of foam cells and 
the stimulation of growth factors and proinflammatory 
cytokines that causes an inflammatory process [19]. The 
inflammatory process brings about an acute phase re-
sponse with the increase in the acute phase proteins which 
are sialylated. Concentrations of acute phase response 
markers and mediators of inflammation such as alpha tu-
mor necrosis factor (TNFα) and interleukin–6 are raised 
in people with type 2 diabetes [20]. If this be the case, 
then the raised concentration of proinflammatory cyto-
kines and the resultant acute phase response may underlie 
much of the metabolic clustering including glucose toler-
ance [19].  Therefore an increase in the acute phase pro-
teins may partly explain the elevation of sialic acid in 
type 2 diabetes mellitus. 
 
In this study we have shown that the concentration of 
sialic acid precedes the manifestation of IGT and lipid 
abnormalities in people in the high risk group for type 2 
diabetes. 
Methodology 
 
Subjects 
 
Healthy control subjects were chosen from Klang valley, 
Kuala Lumpur, through the distribution of questionnaires. 
Any subject with the family history of diabetes, hyperten-
sion, coronary artery disease and a body mass index of 
more than 30kg/m2 was excluded from the study. The 
offspring of at least one parent with type 2 diabetes, with 
and without cardiovascular risk factors were randomly 
recruited through the diabetic clinic, University of Malaya 
Medical Centre, Kuala Lumpur, and through the distribu-
tion of questionnaires. The number of normal subjects 
who participated in this study consisted of seventy four 
subjects and the number of first degree relatives consisted 
of one  hundred and fifty subjects, out of which thirty five 
subjects were classified as having impaired glucose toler-
ance (IGT ) and one hundred and fifteen subjects as hav-
ing normal glucose tolerance (NGT). The subjects were 
classified as having impaired glucose tolerance if the fast-
ing glucose level was equal to or greater than 6mmol/l 
and if the two hour plasma post glucose load value was 
between 7.8 and 11 mmol/l, or as having normal glucose 
tolerance if the fasting level was less than 6 mmol /l and 
the two hour plasma glucose load value were less than 7.8 
mmol/l according to the World Health Organisation [21]. 
None of the subjects received hypolipidemic drug ther-
apy, or had any  renal, hepatic or thyroid disease affecting 
glucose and lipid metabolism. Informed  consent was ob-
tained from all subjects, and the study was approved by 
the institutional ethics committee. 
 
Methods 
 
Fasting blood was collected in bottles containing diso-
dium ethylene diamine tetraacetate Dehydrate (EDTA) 
and the plasma was separated immediately by centrifuga-
tion at 3000 rpm for 15 minutes at 40 C. Total cholesterol, 
triglycerides and high density lipoprotein was determined 
using the individual biochemical kits supplied with di-
mension R clinical chemistry system (Dode Behring 
France) and low density lipoprotein was determined by 
Friedewald equation [22]. Sialic acid was determined by 
the modification of the periodate resorcinol method as 
described by Jourdian et al [23].  
 
Statistical Analysis 
 
Data were expressed as mean ± standard deviation. Con-
tinuous variables were analysed using one way ANOVA. 
Two tailed p value of less than 0.05 was considered sig-
nificant.  
 
Results 
 
The total sialic acid concentration of the controls, off-
spring of one parent with type 2 diabetes with normal 
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glucose tolerance and offspring of one parent with type 2 
diabetes with impaired glucose tolerance are shown in 
Table 1. The two groups were of  comparable age group 
and did not differ significantly in their body mass index. 
The total sialic acid concentration was significantly 
higher in the offspring of one parent with type2 diabetes 
as compared to the control subjects (p < 0.05 ). However 
the total sialic acid concentration was significantly higher  
( p<0.05 ) in the offspring with normal glucose tolerance 
as compared to the offspring with impaired  glucose toler-
ance. 
 
The values of total cholesterol, triglycerides, high density 
lipoprotein and low density lipoprotein of the normals, 
offspring with NGT and offspring with IGT are shown in 
Table 2. The total cholesterol and triglycerides were sig-
nificantly higher ( p <0.05 ) in the offspring with IGT as 
compared to the controls and the offspring with NGT.  
 
Table 1: Sialic acid concentrations 
 
 
Subjects                                   n                          Total sialic acid                   p Concentration 
 
Controls                                    74                        1.97±0.25 m.mole/l   ٭<0.05 
 
Offspring 
IGT                                            35                        2.43±0.35 m.mole/l ٭٭<0.05 
 
Offspring 
NGT                                          115                       3.34±0.6 m.mole/l 
 
Offspring, first degree relative of one parent with type2 diabetes; IGT, impaired glucose tolerance ; NGT, normal glu-
cose tolerance. 
 p<0.05  offspring versus controls;  p < 0.05 NGT vs IGT 
 
Table 2: Plasma lipid levels 
 
Subjects                    n     Total Chol       LDL               HDL            Trig                    p 
            m.mole/l         m.mole/l        m.mole/l      m.mole/l   
                                 
 
Controls                  74        5.20±0.90      3.22±0.91      1.36±0.35       1.04±0.5 
 
Offspring                 35       ٭6.02±1.0      3.85±0.98      1.27±0.35     ٭1.99±1.2     p<0.05 
IGT                
   
Offspring                 115      5.46±0.97      3.56 ±0.91     1.40±0.32      1.20±0.6    
Non IGT 
 
Mean ±SD; Offspring, first degree relative of one parent with type 2 diabetes; IGT, impaired glucose tolerance; NGT, 
normal glucose tolerance. 
The total cholesterol and triglycerides were significantly higher in the offspring with impaired glucose tolerance  
(p<0.05) as compared to the offspring with normal glucose tolerance, and the controls. 
 
Discussion 
 
In this study , the plasma lipid status and plasma sialic 
acid concentrations were evaluated in individuals who are 
genetically at high risk  for developing diabetes but who 
presently do not demonstrate clinical diabetes. The steps 
by which type 2 diabetes causes atherosclerotic vascular 
disease are not clear. 
 
Emphasis is shifting from elucidation of specific meta-
bolic risk factors such as Insulin resistance to an under-
standing of the processes occuring at the level of the vas-
culature and in particular the endothelial cell. Atheroscle-
rotic cardiovascular disease is an inflammatory process 
[18], associated with accumulation of cholesterol carrying 
LDL and fibrinogen/fibrin in the affected arterial wall 
[24]. Therefore it is important to understand the mecha-
nisms which govern endothelial binding, uptake and 
transport of these macromolecules across the vessel wall 
as a prerequisite to the prevention of atherogenesis. The 
role of the luminal endothelial plasma membrane may be 
                    Qvist/ Ismail/ Muniandy/ Lee/ Chinna/ Zaini 
 
 
particularly relevant because it is the first interface be-
tween the vessel wall and circulating  blood components. 
It has been shown that the removal of the surface sialic 
acid from the luminal surface as well as the glycosami-
noglycans increases LDL internalization. Thus the LDL 
uptake is inversely correlated with the sialic acid content 
of the luminal surface  [15]. The internalized LDL is oxi-
dized and is taken up by the macrophages with the forma-
tion of foam cells, which is the first sign of demonstrable 
atherosclerosis causing a localized inflammatory process 
[18]. Therefore we hypothesize that desialylation at the 
endothelium could be an early event in the atherosclerotic 
process and could cause an increase in the sialic acid 
along with the acute phase proteins which results during 
the inflammatory process. 
 
The most important observation in the present study is 
that the total sialic acid was significantly higher ( p<0.05 ) 
in the offspring of one parent with type 2 diabetes (Table 
1). This is in accordance with other studies which have 
shown an increase in sialic acid in relation to cardiovascu-
lar disease and type2 diabetes [25]. 
 
The interesting finding in our study is that amongst the 
offspring the total sialic acid concentration was signifi-
cantly higher (p<0.05) in the offspring with NGT than in 
the offspring with IGT Table 1. One of the plausible ex-
planation is that the offspring with IGT has a higher con-
centration of desialylated LDL. It is well documented that 
the LDL in diabetic patients are desialylated to a greater 
extent than in  the normals and are  responsible for the 
accumulation of LDL in the endothelium and the prema-
ture development of atherosclerosis in diabetic patients 
[9]. It has also been shown that the desialylated LDL is 
catabolised much more rapidly than the sialylated LDL 
[26]. 
 
Our study showed a significant increase in the total cho-
lesterol and triglycerides in the offspring with IGT, when 
compared with the offspring with NGT and control sub-
jects Table 2 .Despite the heterogeneity of atherosclerotic 
risk factors within type 2 diabetes, the offspring  with 
NGT revealed virtually identical lipid profiles with the 
controls who had no family history of diabetes (Table 2). 
 
Other epidemiological studies have shown that the most 
common dyslipidemia in NIDDM and IGT is hyper-
triglyceridemia [27]. However the results concerning se-
rum total and LDL cholesterol levels in patients with 
NIDDM have been conflicting. 
 
The lack of increase in the LDL, in the offspring with 
IGT could be due to the fact that compositional changes 
in LDL may be the first event in the process of atheroscle-
rosis [28] Since the uptake of LDL and the oxidation of 
LDL is the first step in the inflammatory  process of the 
endothelium , leading to atherosclerosis, we postulate that 
the desialylation of the  endothelium may be an early 
event in the atherosclerotic process. 
 
Our preliminary results, which need to be confirmed with 
a larger number of patients show that the concentration of 
total sialic acid precedes any other metabolic disturbances 
in the subjects who are at high risk group for type 2 dia-
betes and subjects with asymptomatic hyperglycemia. 
 
In conclusion our results suggest that there is an increase 
in total sialic acid concentration in the subjects who are 
genetically at high risk, for type 2 diabetes before any 
changes in the glucose tolerance and lipids. Further stud-
ies are in progress involving larger number of well char-
acterized subjects, and utilizing various inflammatory 
markers, to confirm these findings. 
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